Therapeutic Asset Ratings

285 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
LECANEMAB Alzheimers Disease, Familial	Washington University School of Medicine	P3	BB (66)
CARMUSTINE Pediatric Brain Tumor	Washington University School of Medicine	P2	BB (66)
Evomela Wiskott-Aldrich Syndrome	Washington University School of Medicine	P2	BB (66)
FILGRASTIM Lymphoma, Non-Hodgkin	Washington University School of Medicine	P2	BB (66)
Atezolizumab Small Cell Lung Cancer	Washington University School of Medicine	P3	BB (65)
Evomela Childhood Acute Myeloid Leukemia in Remission	Washington University School of Medicine	P2	BB (65)
Flotufolastat F-18 Metastatic Prostate Cancer	Washington University School of Medicine	P4	B (63)
HYDROMORPHON Migraine	Washington University School of Medicine	P4	B (63)
Remternetug Alzheimer Disease	Washington University School of Medicine	P3	B (63)
Evomela Chediak-Higashi Syndrome	Washington University School of Medicine	P2	B (63)
Evomela Inborn Errors of Metabolism	Washington University School of Medicine	P2	B (63)
Polyiclc Melanoma	Washington University School of Medicine	P2	B (63)
LECANEMAB Dementia	Washington University School of Medicine	P3	B (62)
Fludarabine Chediak-Higashi Syndrome	Washington University School of Medicine	P2	B (62)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Chediak-Higashi Syndrome	Washington University School of Medicine	P2	B (62)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Inborn Errors of Metabolism	Washington University School of Medicine	P2	B (62)
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER Wiskott-Aldrich Syndrome	Washington University School of Medicine	P2	B (62)
Polyiclc Metastatic Triple-Negative Breast Carcinoma	Washington University School of Medicine	P2	B (62)
Thiotepa Childhood Diffuse Large Cell Lymphoma	Washington University School of Medicine	P2	B (62)
GENENTECH TAU PROBE 1 Alzheimer's Disease	Washington University School of Medicine	P2	B (61)
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Renal Cell Carcinoma	Washington University School of Medicine	P3	B (60)
Avutometinib Cancer of the Pancreas	Washington University School of Medicine	P2	B (60)
cc-5013 AL Amyloidosis	Washington University School of Medicine	P2	B (60)
Durvalumab Primary CNS Lymphoma	Washington University School of Medicine	P2	B (60)
Evomela Immune Dysregulatory Disorders	Washington University School of Medicine	P2	B (60)

Showing 26 to 50 of 285 assets

PreviousPage 2 of 12Next